NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that it has licensed technology from ActivX Biosciences that it plans to use to develop new mass spectrometry analysis and sample enrichment tools.

The Activity-Based Protein Profiling (ABPP) technology that Thermo Fisher licensed can be used for accurate and broad activity-based profiling of several enzyme families in any biological samples, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.